Double J Stenting and Sildosin After URSL for Lower Ureteric Stones

Inclusion Criteria: * Age \>18 to 60 years, * Diagnosed with lower ureteric stone and those patients willing to participate and follow up in the study. Exclusion Criteria: * Patients having a previous or present history of prostatic or bladder surgery, malignancy, neurological disorder, pelvic irradiation, and diabetes. * Acute or chronic renal insufficiency, solitary kidney or congenital urinary abnormality, cardiac disease, postoperative residual stone fragments, multiple or bilateral ureteral stones, patients with bilateral stents or long-term stenting with frequent change of stents, history of interstitial cystitis, chronic cystitis or prostatitis. * Medical treatment (α blockers, beta-blockers, calcium antagonists, 5 alfa reductase inhibitors, phosphodiesterase type 5 inhibitors, anticholinergics and cholinergic, nitrates). * Pregnant and lactating women and patients not available for follow-up will be excluded from this study.